Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | MTOR | P42345 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.48 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.48 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.37 |
| ▸ | ALB | P02768 | 2/20 | 0.37 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.37 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.37 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.37 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16341980 | 1.00 | LMNA (0.48) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL6832117 | 1.00 | LMNA (0.48) | LMNAMTORTHRBMDM2NCOA1 | |
| Hydrochloric Acid SCHEMBL562424 | 0.99 | LMNA (0.47) | LMNAMTORTHRBMDM2NCOA1 | |
| Phosphoric Acid SCHEMBL21465147 | 0.96 | LMNA (0.45) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL30001975 | 0.88 | LMNA (0.48) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL21586620 | 0.88 | LMNA (0.48) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL17999158 | 0.88 | LMNA (0.48) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL16729899 | 0.88 | LMNA (0.48) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL18013131 | 0.88 | LMNA (0.48) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL13454616 | 0.88 | LMNA (0.48) | LMNAMTORTHRBMDM2NCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2043 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230158000-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING VIRAL HEPATITIS AND THE USE THEREOF | HOLY HAID LAB CORP (CN) | 2023-05-25 | — | — | US | claimed |
| CN-116139161-A | Use of HDAC inhibitors in combination with antimetabolites for combating breast cancer | 深圳微芯生物科技股份有限公司 | 2023-05-23 | — | — | CN | claimed |
| WO-2022160323-A1 | APPLICATION OF NUCLEOSIDE ANALOGUE IN PREPARATION OF DRUGS FOR PREVENTING OR TREATING GASTROINTESTINAL DISEASES | 兰州大学 | 2022-08-04 | — | — | WO | claimed |
| US-20210154200-A1 | 7-BENZYL-4-(METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E]PYRIMIDIN-5 (1H)-ONE, SALTS THEREOF AND METHODS OF USING THE SAME IN COMBINATION THERAPY | ONCOCEUTICS, INC. (US) | 2021-05-27 | — | — | US | claimed |
| CN-106456602-B | Substituted indole MCL-1 inhibitors | 范德比尔特大学 | 2020-11-24 | — | — | CN | claimed |
| EP-3378495-B1 | COMPOSITION COMPRISING NOVEL GLUTAMIC ACID DERIVATIVE AND BLOCK COPOLYMER, AND USE THEREOF | NIPPON KAYAKU KK (JP) | 2020-08-05 | — | — | EP | claimed |
| US-20200190101-A1 | Composition Containing Novel Glutamic Acid Derivative And Block Copolymer, And Use Thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2020-06-18 | — | — | US | claimed |
| WO-2019195494-A1 | COMPOSITIONS AND METHODS FOR SYNTHESIS OF PHOSPHORYLATED MOLECULES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-10-10 | — | — | WO | claimed |
| EP-3378495-A1 | COMPOSITION COMPRISING NOVEL GLUTAMIC ACID DERIVATIVE AND BLOCK COPOLYMER, AND USE THEREOF | Nippon Kayaku Kabushiki Kaisha (JP) | 2018-09-26 | — | — | EP | claimed |
| CN-106163524-A | 7-benzyl-4- (2-methylbenzyl) -2,4,6,7,8, 9-hexahydroimidazo [1,2-a ] pyrido [3,4-e ] pyrimidin-5 (1H) -one, salts thereof, and methods of use | 昂克希尔迪克斯有限公司 | 2016-11-23 | — | — | CN | claimed |
| WO-2008116165-A9 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY INC (US) | 2009-06-11 | — | — | WO | claimed |
| WO-2008116165-A2 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | NEXT SAFETY, INC. (US) | 2008-09-25 | — | — | WO | claimed |
| EP-1968607-A1 | TREATMENT OF CANCER AND OTHER DISEASES | Nabil Habib Lab (LB) | 2008-09-17 | — | — | EP | claimed |
| US-20080066741-A1 | METHODS AND SYSTEMS OF DELIVERING MEDICATION VIA INHALATION | HUNTER, CHARLES ERIC | 2008-03-20 | — | — | US | claimed |
| WO-2007064691-A1 | TREATMENT OF CANCER AND OTHER DISEASES | NABIL HABIB LAB (LB) | 2007-06-07 | — | — | WO | claimed |
| EP-1485395-A2 | NUCLEOTIDE MIMICS AND THEIR PRODRUGS | Biota, Inc. (US) | 2004-12-15 | — | — | EP | claimed |
| WO-2003072757-A9 | NUCLEOTIDE MIMICS AND THEIR PRODRUGS | BIOTA INC (US) | 2004-10-21 | — | — | WO | claimed |
| EP-1448579-A1 | PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES AS ANTITUMORAL MEDICAMENTS | Heidelberg Pharma Holding GmbH (DE) | 2004-08-25 | — | — | EP | claimed |
| WO-2003072757-A2 | NUCLEOTIDE MIMICS AND THEIR PRODRUGS | BIOTA, INC. (US) | 2003-09-04 | — | — | WO | claimed |
| WO-2003044035-A1 | PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES AS ANTITUMORAL MEDICAMENTS | GANYMED 256 VERMÖGENSVERWALTUNGS GMBH (DE) | 2003-05-30 | — | — | WO | claimed |